Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Free Radic Biol Med ; 49(11): 1638-45, 2010 Dec 01.
Article in English | MEDLINE | ID: mdl-20727966

ABSTRACT

The aim of this study was to investigate the involvement of membrane-bound microsomal glutathione transferase 1 (MGST1) in cellular resistance against oxidative stress as well as its mechanism of protection. MGST1 is ubiquitously expressed and predominantly located in the endoplasmic reticulum and outer mitochondrial membrane. Utilizing MCF7 cells overexpressing MGST1 we show significant protection against agents that are known to induce lipid peroxidation (e.g., cumene hydroperoxide and tert-butylhydroperoxide) and an end-product of lipid peroxidation (e.g., 4-hydroxy-2-nonenal). Furthermore, our results demonstrate that MGST1 protection can be enhanced by vitamin E when toxicity depends on oxidative stress, but not when direct alkylation is the dominant mechanism. Mitochondria in MGST1-overexpressing cells were shown to be protected from oxidative insult as measured by calcium loading capacity and respiration. MGST1 induces cellular resistance against cisplatin. Here we used vitamin E to elucidate whether oxidative stress caused by cisplatin is significant for cell toxicity. The results indicate that oxidative stress and induction of lipid peroxidation are not the most prominent toxic mechanism of cisplatin in our cell system. We thus conclude that MGST1 protects cells (and mitochondria) by both conjugation and glutathione peroxidase functions. A new protective mechanism against cisplatin is also indicated.


Subject(s)
Cytoprotection/genetics , Glutathione Transferase/physiology , Aldehydes/toxicity , Antineoplastic Agents/pharmacology , Calcium Signaling/drug effects , Calcium Signaling/genetics , Cisplatin/pharmacology , Cytoprotection/drug effects , Drug Resistance, Neoplasm/genetics , Glutathione Transferase/genetics , Humans , Lipid Peroxides/adverse effects , Lipid Peroxides/pharmacology , Mitochondria/drug effects , Mitochondria/genetics , Mitochondria/metabolism , Mitochondria/physiology , Models, Biological , Signal Transduction/genetics , Transfection , Tumor Cells, Cultured , Vitamin E/pharmacology
2.
Anal Biochem ; 390(1): 52-6, 2009 Jul 01.
Article in English | MEDLINE | ID: mdl-19348782

ABSTRACT

A new thiol-reactive electrophilic, disubstituted rhodamine-based fluorogenic probe (bis-2,4-dinitrobenzenesulfonyl rhodamine [BDR]) with very high quantum yield was synthesized and described recently [A. Shibata et al., Bioorg. Med. Chem. Lett. 18 (2008) 2246-2249]. Because hydrophobic electrophiles are often conjugated by glutathione transferases, the BDR or monosubstituted rhodamine derivatives (2,4-dinitrobenzenesulfonyl rhodamine [DR]) were tested with microsomal glutathione transferase 1 (MGST1) and shown to function as substrates. The kinetic parameters for purified enzyme and DR were k(cat)=0.075+/-0.005 s(-1) and K(m)=21+/-3 microM (k(cat)/K(m)=3.6 x 10(3)+/-5.6 x 10(2)M(-1)s(-1)), giving a rate enhancement of 10(6) compared with the nonenzymatic reaction. In cells overexpressing MGST1, the addition of BDR caused a time-dependent increase of fluorescence compared with control cells. Preincubating the cells with a thiol reagent (N-ethylmaleimide) abolished the fluorescent signal. By using DR, we could determine the MGST1 activity in whole cell extracts with high sensitivity. In addition, the activity could be increased by thiol reagents (a hallmark of MGST1). Thus, we have identified a new fluorogenic substrate for MGST1 that will be a useful tool in the study of this enzyme and related enzymes.


Subject(s)
Fluorescent Dyes/chemistry , Glutathione Transferase/metabolism , Microsomes, Liver/enzymology , Rhodamines/chemistry , Sulfonamides/chemistry , Animals , Cell Line, Tumor , Humans , Kinetics , Rats , Rats, Sprague-Dawley , Rhodamines/metabolism , Substrate Specificity , Sulfonamides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...